| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/01/2022 | — | Northcoast Research | Upgrades | Neutral → Buy | |
| 11/14/2022 | 6.54% | Deutsche Bank | $36 → $35 | Maintains | Hold |
| 09/06/2022 | 9.59% | Deutsche Bank | $26 → $36 | Maintains | Hold |
| 08/19/2022 | -5.63% | BMO Capital | $29 → $31 | Maintains | Market Perform |
| 06/07/2022 | -11.72% | BMO Capital | $24 → $29 | Maintains | Market Perform |
| 06/03/2022 | -20.85% | Deutsche Bank | $25 → $26 | Maintains | Hold |
| 03/21/2022 | — | CL King | Initiates Coverage On | → Neutral | |
| 11/15/2021 | -49.77% | Northcoast Research | → $16.5 | Downgrades | Buy → Neutral |
| 01/07/2021 | -45.21% | Barclays | → $18 | Downgrades | Equal-Weight → Underweight |
| 08/17/2020 | -36.07% | Deutsche Bank | $20 → $21 | Maintains | Hold |
| 07/17/2020 | — | BTIG | Initiates Coverage On | → Neutral | |
| 03/19/2020 | -54.34% | Barclays | → $15 | Upgrades | Underweight → Equal-Weight |
| 03/18/2020 | -57.38% | BMO Capital | $10 → $14 | Upgrades | Underperform → Market Perform |
| 08/13/2019 | -75.65% | Barclays | $13 → $8 | Maintains | Underweight |
| 08/02/2019 | -75.65% | BMO Capital | $13 → $8 | Downgrades | Market Perform → Underperform |
| 06/25/2019 | -54.34% | Loop Capital | → $15 | Initiates Coverage On | → Buy |
| 01/10/2019 | -23.9% | RBC Capital | → $25 | Initiates Coverage On | → Outperform |
| 11/09/2018 | -29.98% | BMO Capital | → $23 | Downgrades | Outperform → Market Perform |
| 08/17/2018 | -39.12% | Deutsche Bank | $21 → $20 | Maintains | Hold |
| 08/17/2018 | -29.98% | BMO Capital | $25 → $23 | Maintains | Outperform |
| 05/31/2018 | -29.98% | Barclays | $17 → $23 | Maintains | Equal-Weight |
| 05/31/2018 | -23.9% | BMO Capital | $23 → $25 | Maintains | Outperform |
| 03/02/2018 | — | BMO Capital | Upgrades | Market Perform → Outperform | |
| 02/22/2018 | -36.07% | Deutsche Bank | $24 → $21 | Maintains | Hold |
| 01/05/2018 | — | Northcoast Research | Downgrades | Buy → Neutral |
What is the target price for SpartanNash (SPTN)?
The latest price target for SpartanNash (NASDAQ: SPTN) was reported by Northcoast Research on December 1, 2022. The analyst firm set a price target for $0.00 expecting SPTN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SpartanNash (SPTN)?
The latest analyst rating for SpartanNash (NASDAQ: SPTN) was provided by Northcoast Research, and SpartanNash upgraded their buy rating.
When is the next analyst rating going to be posted or updated for SpartanNash (SPTN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SpartanNash, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SpartanNash was filed on December 1, 2022 so you should expect the next rating to be made available sometime around December 1, 2023.
Is the Analyst Rating SpartanNash (SPTN) correct?
While ratings are subjective and will change, the latest SpartanNash (SPTN) rating was a upgraded with a price target of $0.00 to $0.00. The current price SpartanNash (SPTN) is trading at is $32.85, which is out of the analyst's predicted range.